Fingerprint
Dive into the research topics of 'A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Joseph Mikhael, Joshua Richter, Ravi Vij, Craig Cole, Jeffrey Zonder, Jonathan L. Kaufman, William Bensinger, Meletios Dimopoulos, Nikoletta Lendvai, Parameswaran Hari, Enrique M. Ocio, Cristina Gasparetto, Shaji Kumar, Corina Oprea, Marielle Chiron, Claire Brillac, Eric Charpentier, Jesús San-Miguel, Thomas Martin
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations